Epigenetic Drivers of Cancer
Sarah Shareef
Sarah is developing technologies to study the contribution of aberrant DNA methylation to tumor pathogenesis MD/PhD student in Harvard-MIT MD/PhD Program Health Sciences and Technology (HST) Program at Harvard Medical School Systems Biology PhD program